Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2007-04-23
Summary
The objective of this proposal is to study the applicability of the hs-CRP assay in the assessment of CV risk in daily clinical conditions where hyperlipidemic population with or without CHD are currently evaluated.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
CHU de Quebec-Universite Laval
lead OTHER
Principal Investigators
-
Jean Bergeron, MD MSc FRCPC · CHUL Research Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-03-31
- Completion
- 2006-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease
NCT03868332 ·Status: UNKNOWN
-
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NCT05670301 ·Status: RECRUITING ·Phase: NA
-
Hematological Disorders in Covid 19 Patients
NCT05182528 ·Status: UNKNOWN
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis
NCT03114267 ·Status: COMPLETED
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells
NCT02545387 ·Status: WITHDRAWN
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 ·Status: UNKNOWN
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
CRP /albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
NCT06750315 ·Status: NOT_YET_RECRUITING
-
Hepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371 ·Status: COMPLETED
-
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NCT03773887 ·Status: RECRUITING ·Phase: NA
-
Inflammatory Marker in Ibd and Peripheral Arthritis
NCT05705232 ·Status: UNKNOWN
-
THE RELATIONSHIP OF CRP/ALBUMIN RATIO LEVEL AND PROGNOSIS IN PREGNANT COVID-19 PATIENTS
NCT05242172 ·Status: UNKNOWN
-
VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
NCT04587323 ·Status: COMPLETED
-
Examining Macrophage Influx and Vascularization in Chronic Pancreatitis
NCT00491023 ·Status: COMPLETED
-
H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
NCT06586567 ·Status: NOT_YET_RECRUITING
-
B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
NCT01568736 ·Status: WITHDRAWN
-
Progranulin and CTRP3 in Metabolic Syndrome
NCT01668888 ·Status: COMPLETED
-
Prevalence of H.Pylori in CKD Patients
NCT05882968 ·Status: UNKNOWN